Literature DB >> 12798638

Immunity against measles in populations of women and infants in Poland.

Wieslawa Janaszek1, Janusz Slusarczyk.   

Abstract

During the 1997-1998 measles epidemic in Poland a high attack rate occurred in infants up to 1 year of age (24.6/100,000 in comparison with 5.5/100,000 in total population). Routine vaccination against measles for infants aged 13-15 months was introduced in Poland in 1975, and a second dose added in 1991. The recommended age for measles vaccination was based on information gathered in years when most mothers had a natural measles. Nowadays, many mothers have received measles vaccine. Early loss of passively acquired measles antibody may occur in infants of women who received measles vaccine, because measles vaccine induces lower antibody titres than does natural infection. Therefore, measles-specific antibody titres were determined among vaccinated and unvaccinated women as well as among infants, whose mothers were born after 1976 and likely were vaccinated (Group 1), and those, whose mothers were born before 1969 and likely have had a natural measles (Group 2). All women that were born in prevaccination era had significantly higher geometric mean titre (GMT) of measles antibody than those who were vaccinated (P<0.001). Also infants from Group 2 at every age had higher GMT of measles antibody than those of Group 1. The antibody decay was significantly faster among infants whose mothers acquired immunity by measles vaccination. Because nowadays the majority of women in childbearing age are vaccinated against measles, earlier vaccination in the infants should be considered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12798638     DOI: 10.1016/s0264-410x(03)00113-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Age-related changes in serological susceptibility patterns to measles: results from a seroepidemiological study in Dongguan, China.

Authors:  Yongzhen Xiong; Dong Wang; Weiyan Lin; Hao Tang; Shaoli Chen; Jindong Ni
Journal:  Hum Vaccin Immunother       Date:  2014-01-21       Impact factor: 3.452

2.  Kinetics of decline of maternal measles virus-neutralizing antibodies in sera of infants in France in 2006.

Authors:  Arnaud Gagneur; Didier Pinquier; Marie Aubert; Laurent Balu; Olivier Brissaud; Loïc De Pontual; Christèle Gras Le Guen; Isabelle Hau-Rainsard; Olivier Mory; Georges Picherot; Jean-Louis Stephan; Bernard Cohen; Evelyne Caulin; Benoît Soubeyrand; Philippe Reinert
Journal:  Clin Vaccine Immunol       Date:  2008-09-24

3.  The epidemiological and serological characteristics of measles in Dongguan, China, 2005-2014.

Authors:  Ke Han; Shaoli Chen; Cuifei Tang; Jinjun Wen; Jingquan Li; Jindong Ni; Xueli Zheng
Journal:  Hum Vaccin Immunother       Date:  2016-03-22       Impact factor: 3.452

4.  Measles vaccine coverage estimates in an outbreak three years after the nation-wide campaign in China: implications for measles elimination, 2013.

Authors:  Chao Ma; Fangjun Li; Xiang Zheng; Hong Zhang; Mengjuan Duan; Yanhua Yang; Lixin Hao; Qiru Su; Lance Rodewald; Bosong Guo; Shanliang Xiao; Huaqing Wang; Li Li; Junhua Li; Huiming Luo; Lidong Gao
Journal:  BMC Infect Dis       Date:  2015-01-22       Impact factor: 3.090

5.  Modelling the effect of a booster vaccination on disease epidemiology.

Authors:  M E Alexander; S M Moghadas; P Rohani; A R Summers
Journal:  J Math Biol       Date:  2005-11-10       Impact factor: 2.164

6.  Timeliness vaccination of measles containing vaccine and barriers to vaccination among migrant children in East China.

Authors:  Yu Hu; Qian Li; Shuying Luo; Linqiao Lou; Xiaohua Qi; Shuyun Xie
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

7.  Decreasing Seroprevalence of Measles Antibodies after Vaccination - Possible Gap in Measles Protection in Adults in the Czech Republic.

Authors:  Jan Smetana; Roman Chlibek; Irena Hanovcova; Renata Sosovickova; Libuse Smetanova; Peter Gal; Petr Dite
Journal:  PLoS One       Date:  2017-01-13       Impact factor: 3.240

8.  Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants.

Authors:  Jolice P van den Berg; Elisabeth A M Westerbeek; Gaby P Smits; Fiona R M van der Klis; Guy A M Berbers; Ruurd M van Elburg
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

9.  Measles susceptibility in maternal-infant dyads-Bamako, Mali.

Authors:  Meredith G Dixon; Milagritos D Tapia; Kathleen Wannemuehler; Richard Luce; Mark Papania; Samba Sow; Myron M Levine; Marcela F Pasetti
Journal:  Vaccine       Date:  2022-01-31       Impact factor: 3.641

10.  Measles, rubella, mumps and Toxoplasma gondii antibodies in saliva of vaccinated students of schools and universities in São Paulo City, Brazil.

Authors:  Barbara Carvalho Fialho Sampaio; Jaqueline Polizeli Rodrigues; Luciana Regina Meireles; Heitor Franco de Andrade Junior
Journal:  Braz J Infect Dis       Date:  2019-12-19       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.